QOF 2026/27: the operational changes practices cannot afford to miss

The 2026/27 QOF changes contain a number of themes that look relatively modest in isolation, but together they point to something much bigger: a continued shift away from narrow indicator compliance and towards operational delivery.

Focus areas

Obesity, diabetes, frailty, respiratory disease and heart failure

Core theme

Operational delivery now matters as much as indicator knowledge

Practical takeaway

Audit the cohort, check the coding, redesign the workflow, and do it early

QOF 2026/27 overview graphic
A practical overview of the main QOF 2026/27 operational changes affecting general practice.

1. Obesity: from register logic to pathway logic

Back to top

A key point of clarification is that OB003 was the previous obesity register indicator and was retired, while OB004 and OB005 are the live indicators for 2026/27.

That matters because this is not a case of one indicator simply being renamed. It is a change in structure.

OB004

Focused on identifying patients with raised BMI and referring eligible patients into weight management support within the required timeframe.

OB005

More demanding, with higher BMI thresholds, ethnicity-related thresholds, comorbidity requirements, behavioural support, pharmacotherapy considerations, shared decision-making requirements and more detailed exclusion logic.

Operationally, this means practices need more than coding awareness. They need:

  • reliable case finding
  • blood and comorbidity review
  • clear referral pathways
  • consistent documentation
  • a shared understanding across admin and clinical teams
Diabetes QOF 2026 2027 summary graphic
Diabetes changes: expanded NDH003 scope and DM037 moving beyond a simple foot check requirement.

2. Diabetes: small wording changes, bigger delivery consequences

Back to top

NDH003: not a new indicator, but an expanded one

NDH003 is not new. The key change is that gestational diabetes is now being added into scope alongside the existing non-diabetic hyperglycaemia cohort.

That sounds modest, but the operational consequences may be significant.

  • whether historic gestational diabetes coding is complete enough to identify the right patients
  • what extra recall volume this creates
  • whether HbA1c capacity is sufficient
  • whether the recall process already accommodates this new cohort
  • how patients will respond when contacted unexpectedly

This is less a “new indicator” problem than a coding, recall and capacity problem.

DM037: no longer just a foot check story

The other major diabetes change is the move from DM012 to DM037.

Previously, the focus was much narrower and more closely associated with the foot risk check. Now, DM037 requires the full set of key care process elements to be recorded.

That changes the operational task completely.

Practices may need to review:

  • template design
  • review workflow
  • task ownership
  • incomplete review follow-up
  • coding consistency
  • clinical and nursing capacity
Frailty QOF 2026 2027 summary graphic
Frailty changes: Rockwood scoring no longer driving the same eligibility logic, with knock-on effects for linked pathways.

3. Frailty: coding changes with knock-on effects elsewhere

Back to top

Historically, many practices will have used Rockwood Clinical Frailty Scale coding as part of how frailty status was recorded and operationalised.

The 2026/27 change means that Rockwood scores no longer appear to drive eligibility or linked logic in the same way. What matters now is explicit coding of:

  • moderate frailty
  • severe frailty

This has wider consequences because frailty status can affect:

  • blood pressure lead indicators
  • HbA1c-related pathways
  • other linked indicator logic where moderate or severe frailty changes the target or process applied

If the frailty code is wrong, the patient may not just be missing from a frailty cohort. They may be sitting in the wrong pathway elsewhere too.

Respiratory QOF 2026 2027 summary graphic
Respiratory changes: asthma age threshold shifts to 5+ and COPD register composition may move unexpectedly.

4. Respiratory: asthma recall pressure and COPD register drift

Back to top

Asthma: age threshold shifts from 6+ to 5+

All asthma indicators now apply from age 5, rather than age 6.

On paper, this looks like a very small rule change. In reality, it may alter:

  • recall cohorts
  • nursing workload
  • review appointment demand
  • new diagnosis follow-up processes

COPD: register composition may change unexpectedly

The COPD changes are more subtle and may be more disruptive.

The register can now be influenced by diagnosis codes and procedure/monitoring codes, including recent monitoring activity.

That means practices may see denominator movement compared with previous years, including:

  • patients added because of historic procedure or monitoring codes
  • patients whose coding does not reflect a clean diagnostic pathway
  • register noise caused by older coding habits or template behaviour
Heart failure QOF 2026 2027 summary graphic
Heart failure changes: HF009 depends on identifying the right HFrEF cohort and closing four-pillar treatment gaps.

5. Heart failure: register accuracy plus medicines optimisation

Back to top

The heart failure changes centred on HF009 are another example of how QOF is becoming more specific and more operationally demanding.

HF009 is focused on heart failure with reduced ejection fraction (HFrEF), not just general heart failure.

That means the first challenge is identifying the right denominator.

Practices need to know:

  • who has echo evidence of reduced ejection fraction
  • whether that has been translated into the right diagnosis code
  • whether the HFrEF register is accurate
  • whether general heart failure codes are masking patients who should sit in the more specific HFrEF cohort

Once that is correct, the second challenge is treatment optimisation.

Achievement depends on evidence of prescribing across the 4 therapy pillars in the last 6 months of the year:

  • ACEi / ARB / ARNI
  • licensed beta blocker
  • mineralocorticoid receptor antagonist
  • SGLT2 inhibitor
Common QOF themes summary graphic
Common themes across the 2026/27 contract: coding accuracy, register quality, recall design, workflow reliability and early-year action.

What ties all of this together?

Back to top

Each of these changes is different, but the pattern is remarkably consistent.

The 2026/27 contract is pushing practices towards stronger operational discipline in five areas:

1. Coding accuracy

Not just “is there a code?”, but “is it the right code to drive the right pathway?”

2. Register quality

Multiple indicators now depend on whether the denominator genuinely reflects the intended clinical cohort.

3. Recall design

Changes in scope, eligibility and age thresholds mean recall systems may need redesign, not just minor adjustment.

4. Review workflow

Achievement is increasingly dependent on multiple steps being completed and recorded reliably across one pathway.

5. Early-year management

These are not indicators that lend themselves well to year-end rescue work. They reward practices that identify gaps early and work them systematically.

Final thought

The biggest risk with the 2026/27 QOF changes is not misunderstanding the contract wording.

It is assuming that small wording changes will only create small operational consequences.

In reality, several of this year’s changes affect:

  • who is in the denominator
  • what has to be coded
  • what has to be reviewed
  • what has to be prescribed
  • what has to be followed up
  • and how complete the process has to be before achievement happens

If there is one practical takeaway, it is this: audit the cohort, check the coding, redesign the workflow, and do it early.